Sign in

CIK 0001671584

  • Non-accelerated filer
  • Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811567056
Phone
+1 206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-18 Mitchell Shawnte SVP, GC and Corporate Affairs Grant or award · Stock Option (right to buy) +134,800 134,800
2019-11-01 Mitchell Shawnte SVP, GC and Corporate Affairs Grant or award · Stock Option (right to buy) +120,968 120,968
2019-03-01 Mitchell Shawnte SVP, GC and Corporate Affairs Option exercise +6,787 82,539
2019-03-01 Mitchell Shawnte SVP, GC and Corporate Affairs Shares withheld for taxes −2,012 $1.57 $3K 80,527
2019-03-01 Mitchell Shawnte SVP, GC and Corporate Affairs Option exercise · Restricted Stock Unit −6,787 0
2019-02-28 Mitchell Shawnte SVP, GC and Corporate Affairs Grant or award · Stock Option (right to buy) +67,400 67,400
2018-08-09 Mitchell Shawnte SVP, GC and Corporate Affairs Option exercise +1,630 76,135
2018-08-09 Mitchell Shawnte SVP, GC and Corporate Affairs Shares withheld for taxes −383 $4.50 $2K 75,752
2018-08-09 Mitchell Shawnte SVP, GC and Corporate Affairs Option exercise · Restricted Stock Units −1,630 6,787

Page 1 of 1 · 9 trades